(S (NP (PRP It)) (VP (VBZ is) (ADVP (RB widely)) (VP (VBN accepted) (SBAR (IN that) (S (NP (DT the) (JJ immune) (NN system)) (VP (VBZ undergoes) (NP (NP (ADJP (NN age) (HYPH -) (VBN related)) (NNS changes)) (VP (VBG correlating) (PP (IN with) (NP (NP (VBN increased) (NN disease)) (PP (IN in) (NP (DT the) (JJ elderly)))))))))))) (. .))
(S (NP (NML (NN T) (NN cell)) (NNS subsets)) (VP (VBP have) (VP (VBN been) (VP (VBN implicated)))) (. .))
(S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT this) (NN work)))) (VP (VBZ is) (ADVP (RB firstly)) (S (VP (TO to) (VP (VB implement) (CC and) (VB validate) (NP (NP (DT a) (NN simulation)) (PP (IN of) (NP (NNP T) (NML (NML (JJ regulatory) (NN cell)) (-LRB- -LRB-) (NML (NP (NNP Treg))) (-RRB- -RRB-)) (NNS dynamics)))) (PP (IN throughout) (NP (DT the) (NN lifetime))) (, ,) (PP (VBN based) (PP (IN on) (NP (NP (DT a) (NN model)) (PP (IN by) (NP (NNP Baltcheva)))))))))) (. .))
(S (NP (PRP We)) (VP (VBP show) (SBAR (IN that) (S (NP (PRP$ our) (JJ initial) (NN simulation)) (VP (VP (VBZ produces) (NP (NP (DT an) (NN inversion)) (PP (IN between) (NP (NN precursor))))) (CC and) (VP (VBP mature) (NP (NNP Treys)) (PP (IN at) (NP (NP (QP (RB around) (CD 20)) (NNS years)) (PP (IN of) (NP (NN age))))))))) (, ,) (SBAR (IN though) (S (NP (DT the) (NN output)) (VP (VBZ differs) (ADVP (RB significantly)) (PP (IN from) (NP (DT the) (JJ original) (NN laboratory) (NN dataset))))))) (. .))
(S (ADVP (RB Secondly)) (, ,) (NP (DT this) (NN report)) (VP (VBZ discusses) (NP (NP (NN development)) (PP (IN of) (NP (DT the) (NN model) (S (VP (TO to) (VP (VB incorporate) (NP (JJ new) (NNS data)) (PP (IN from) (NP (NP (DT a) (JJ cross-sectional) (NN study)) (PP (IN of) (NP (NP (JJ healthy) (NN blood) (NNS donors)) (VP (VBG addressing) (NP (NP (NP (NN balance)) (PP (IN between) (NP (NNP Treys)))) (CC and) (NP (NP (NN Th17) (NNS cells)) (PP (IN with) (NP (NP (JJ novel) (NNS markers)) (PP (IN for) (NP (NNP Treg))))))))))))))))))) (. .))
(S (NP (NP (DT The) (NN potential)) (PP (IN for) (NP (NN simulation) (S (VP (TO to) (VP (VB add) (NP (NN insight)) (PP (IN into) (NP (JJ immune) (NN aging))))))))) (VP (VBZ is) (VP (VBN discussed))) (. .))
